Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
Background: Oral anticoagulants (OAC) plus antiplatelets is recommended for patients with atrial fibrillation (AF) and coronary artery disease (CAD) to reduce thromboembolism. However, there is limited evidence regarding antithrombotic therapy for patients with concomitant chronic kidney disease (CK...
Main Authors: | Kuo-Hua Lee, Shuo-Ming Ou, Yuan-Chia Chu, Yao-Ping Lin, Ming-Tsun Tsai, Der-Cherng Tarng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.751359/full |
Similar Items
-
Beyond a Measure of Liver Function—Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients
by: Ming-Tsun Tsai, et al.
Published: (2018-12-01) -
Comparison of Simplified Creatinine Index and Systemic Inflammatory Markers for Nutritional Evaluation of Hemodialysis Patients
by: Ming-Tsun Tsai, et al.
Published: (2021-05-01) -
Impacts of Heart Failure and Physical Performance on Long-Term Mortality in Old Patients With Chronic Kidney Disease
by: Shuo-Chun Weng, et al.
Published: (2021-06-01) -
Iron Therapy in Chronic Kidney Disease: Days of Future Past
by: Kuo-Hua Lee, et al.
Published: (2021-01-01) -
Impact of physical activity on the association between lipid profiles and mortality among older people
by: Shuo-Ming Ou, et al.
Published: (2017-08-01)